Pathological analyses of long-term intracoronary Palmaz-Schatz stenting: Is its efficacy permanent?

Cardiovascular Pathology

Volumn 13, Issue 2, 2004, Pages 109-115

  Inoue, Katsumi ^a   Abe, Kenichi ^a   Ando, Kenji ^a   Shirai, Shinichi ^a   Nishiyama, Kei ^a   Nakanishi, Michio ^a   Yamada, Takashi ^a   Sakai, Koyu ^a   Nakagawa, Yoshihisa ^a   Hamasaki, Naoya ^a   Kimura, Takeshi ^a   Nobuyoshi, Masakiyo ^a   Miyamoto, Tadaomi Alfonso ^b  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Inflammation; Pathology; Stents

Indexed keywords

COLLAGEN; COLLAGEN FIBER; LIPID; METALLOPROTEINASE; STAINLESS STEEL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FOREIGN BODY REACTION; GIANT CELL; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INTIMA; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MATURATION; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; RESTENOSIS; SCAR; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; THROMBUS; TIME; TREATMENT OUTCOME;

AGED; CORONARY RESTENOSIS; CORONARY VESSELS; FEMALE; FOREIGN-BODY REACTION; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; STAINLESS STEEL; STENTS; TIME FACTORS;

EID: 12144288756     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(03)00132-7     Document Type: Article

References (24)

1. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P., Belardi J., Sigwart U., Colombo A., Goy J.J., van den, Heuvel P., Delcan J., Morel M.A. for the Benesetent Study Group A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
2. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M., Cleman M., Heuser R., Almond D., Teirstein P.S., Fish R.D., Colombo A., Brinker J., Moses J., Shaknovich A., Hirshfeld J., Bailey S., Ellis S., Rake R., Goldberg S. for the Stent Restenosis Study Investigators A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
3. Karam C., Fajadet J., Beauchet A., Cassagneau B., Marco J. Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease. Catheter Cardiovasc Interv. 50:2000;170-174.
4. Choussat R., Klersy C., Black A.J.R., Bossi I., Laurent J.P., Jordan C., Guagliumi G., Fajadet J., Marco J. Long-term (≧8 years) outcome after Palmaz-Schatz stent implantation. Am J Cardiol. 88:2001;10-16.
5. Topol E.J. CAVEATS about elective coronary stenting. N Engl J Med. 331:1994;539-541.
6. Kimura T., Yokoi H., Nakagawa Y., Tamura T., Kaburagi S., Sawada Y., Sato Y., Yokoi H., Hamasaki N., Nosaka H., Nobuyoshi M. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 334:1996;561-566.
7. Kimura T., Abe K., Shizuta S., Odashiro K., Yoshida Y., Sakai K., Kaitani K., Inoue K., Nakagawa Y., Yokoi H., Iwabuchi M., Hamasaki N., Nosaka H., Nobuyoshi M. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation. 105:2002;2986-2991.
8. Inoue K., Harada T. Induction of granulopoiesis of mastocytoma cells: ultrastructural and cytochemical studies on production of serotonin in a cultured mouse mastocytoma cell line. Virchows Archiv B. 53:1987;153-160.
9. Nobuyoshi M., Kimura T., Ohishi H., Horiuchi H., Nosaka H., Hamasaki N., Yokoi H., Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol. 17:1991;433-439.
10. Komatsu R., Ueda M., Naruko T., Kojima A., Becker A.E. Neointimal tissue response at coronary stenting sites in humans: macroscopic, histological, and immunohistochemical analysis. Circulation. 98:1998;224-233.
11. Cramers M., Lucht U. Metal sensitivity in patients treated for tibial fractures with plates of stainless steel. Acta Orthop Scand. 48:1977;245-249.
12. Köster R., Vieluf D., Kiehn M., Sommerauer M., Kähler J., Baidus S., Meinertz T., Hamm C.W. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet. 356:2000;1895-1897.
13. Grewe P.H., Deneke T., Machraoui A., Barmeyer J., Muller K.M. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol. 35:2000;157-163.
14. Farb A., Weber D.K., Kolodgie F.D., Burke A.P., Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 105:2002;2974-2980.
15. Anderson J.M. Inflammatory response to implants. ASAIO Trans. 11:1988;101-107.
16. de Boer O.J., van der Wal A.C., Teeling P., Becker A.E. Leukocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res. 41:1999;443-449.
17. Xu X-P, Meisel S.R., Ong J.M., Kaul S., Cercek B., Rajavashisth T.B., Sharifi B., Shah P.K. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation. 99:1999;993-998.
18. Lee R., Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 17:1997;1859-1867.
19. Mann J., Davies M.J. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 82:1999;265-268.
20. Libby P. Molecular basis of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
21. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126.
22. Vaughan C.J., Gotto A.M., Basson C.T. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 35:2000;1-10.
23. Aikawa M., Rabkin E., Sugiyama S., Voglic S.J., Fukumoto Y., Furukawa Y., Shiomi M., Schoen F.J., Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix matalloproteinases and tissue factor in vivo and in vitro. Circulation. 103:2001;276-283.
24. Bellosta S., Via D., Canavesi M., Pfister P., Fumagalli R., Paoletti R., Bernini F. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol. 18:1998;1671-1678.